Breaking News Instant updates and real-time market news.

2022-12-03 08:31:53 TOL Toll Brothers $47.89 / -0.45 (-0.93%) 08:31 12/03/22 12/03 08:31 12/03/22 08:31	Housing stocks are down, but there are signs of rebound, Barron's says Housing-related stocks have taken some big hits this year, but the stocks are now trading at attractive price/earnings ratios, Andrew Bary writes in this week's edition of Barron's. However, there remain many negatives, some bigger than others. Housing affordability measures have plunged for first-time buyers and even wealthier move-up purchasers. New orders are off sharply, with Toll Brothers reporting a 60% drop in the most recent quarter, the author notes. Much of the bad news-and little of the potential good-looks priced into housing stocks, and waiting for fundamentals to improve might mean waiting too long, Bary writes. Reference Link	07 Dec

2022-12-03 08:31:53

TOL

Toll Brothers

$47.89 / -0.45 (-0.93%)

08:31

12/03/22

12/03

08:31

12/03/22

08:31

Housing stocks are down, but there are signs of rebound, Barron's says

Housing-related stocks have taken some big hits this year, but the stocks are now trading at attractive price/earnings ratios, Andrew Bary writes in this week's edition of Barron's. However, there remain many negatives, some bigger than others. Housing affordability measures have plunged for first-time buyers and even wealthier move-up purchasers. New orders are off sharply, with Toll Brothers reporting a 60% drop in the most recent quarter, the author notes. Much of the bad news-and little of the potential good-looks priced into housing stocks, and waiting for fundamentals to improve might mean waiting too long, Bary writes. Reference Link

07
Dec

OTHER BREAKING NEWS FROM THE FLY

Syndicate	Leafly files to sell 17.34M shares of common stock for holders 08:43 03/29/23 03/29 08:43 03/29/23 08:43 LFLY Leafly / + ShowHide Related Items >><< Company News Street Research Earnings LFLY Leafly / + 10/24/22 Leafly appoints Carlos Pinto as chief commercial officer 10/18/22 Leafly to cut 56 positions as part of cost reductions 10/16/22 Uber Eats, Leafly partner to bring cannabis delivery to Torontonians LFLY Leafly / + 08/12/22 Oppenheimer Oppenheimer says Leafly valuation 'beginning to look attractive' 08/12/22 Cowen Leafly price target lowered to $4 from $12 at Cowen 08/12/22 Benchmark Leafly price target lowered to $6.50 from $12.00 at Benchmark 05/20/22 Cowen Cowen starts Leafly with Outperform with its early mover advantage LFLY Leafly / + 03/16/23 Leafly sees Q1 revenue $11M-$11.3M, consensus $12.11M 03/16/23 Leafly reports Q4 EPS (17c), consensus (18c) 11/10/22 Leafly now sees FY22 revenue $47M-$48M, consensus $48.15M 11/10/22 Leafly reports Q3 EPS 28c, consensus (18c)
Syndicate	Leafly files $75M mixed securities shelf 08:43 03/29/23 03/29 08:43 03/29/23 08:43 LFLY Leafly / + ShowHide Related Items >><< Company News Street Research Earnings LFLY Leafly / + 10/24/22 Leafly appoints Carlos Pinto as chief commercial officer 10/18/22 Leafly to cut 56 positions as part of cost reductions 10/16/22 Uber Eats, Leafly partner to bring cannabis delivery to Torontonians LFLY Leafly / + 08/12/22 Oppenheimer Oppenheimer says Leafly valuation 'beginning to look attractive' 08/12/22 Cowen Leafly price target lowered to $4 from $12 at Cowen 08/12/22 Benchmark Leafly price target lowered to $6.50 from $12.00 at Benchmark 05/20/22 Cowen Cowen starts Leafly with Outperform with its early mover advantage LFLY Leafly / + 03/16/23 Leafly sees Q1 revenue $11M-$11.3M, consensus $12.11M 03/16/23 Leafly reports Q4 EPS (17c), consensus (18c) 11/10/22 Leafly now sees FY22 revenue $47M-$48M, consensus $48.15M 11/10/22 Leafly reports Q3 EPS 28c, consensus (18c)
Initiation	InMode initiated with a Buy at UBS » 08:42 03/29/23 03/29 08:42 03/29/23 08:42 INMD InMode $29.98 / -0.395 (-1.30%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options INMD InMode $29.98 / -0.395 (-1.30%) 03/13/23 InMode does not hold cash deposits as Silicon Valley Bank INMD InMode $29.98 / -0.395 (-1.30%) 03/28/23 UBS InMode initiated with a Buy at UBS 02/17/23 Needham Needham downgrades InMode after aesthetics patient survey 02/17/23 Needham InMode downgraded to Hold from Buy at Needham 02/15/23 Barclays InMode price target raised to $45 from $44 at Barclays INMD InMode $29.98 / -0.395 (-1.30%) 02/14/23 InMode sees FY23 adjusted EPS $2.58-$2.60, consensus $2.64 02/14/23 InMode reports Q4 adjusted EPS 78c, consensus 67c 01/11/23 InMode sees FY23 revenue $525M-$530M, consensus $523.86M 01/11/23 InMode raises FY22 adjusted EPS view to $2.38-$2.39 from $2.28-$2.30 INMD InMode $29.98 / -0.395 (-1.30%) 01/11/23 What You Missed On Wall Street This Morning 10/13/22 What You Missed On Wall Street On Thursday 10/13/22 What You Missed On Wall Street This Morning INMD InMode $29.98 / -0.395 (-1.30%) 02/10/23 InMode put volume heavy and directionally bearish 11/28/22 InMode call volume above normal and directionally bullish 10/28/22 InMode put volume heavy and directionally bearish
Recommendations	American Eagle price target lowered to $19 from $22 at UBS » 08:42 03/29/23 03/29 08:42 03/29/23 08:42 AEO American Eagle $13.11 / +0.125 (+0.96%) UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options AEO American Eagle $13.11 / +0.125 (+0.96%) 03/28/23 RADAR to launch new technology in American Eagle stores 03/27/23 e.l.f. Beauty, American Eagle announce beauty collaboration 01/09/23 American Eagle reports quarter-to-date brand revenue down 3% 01/05/23 Land's End announces leadership appointments, organizational changes AEO American Eagle $13.11 / +0.125 (+0.96%) 03/03/23 Barclays American Eagle price target raised to $16 from $15 at Barclays 02/15/23 Jefferies American Eagle downgraded to Hold from Buy at Jefferies 01/13/23 Barclays American Eagle price target lowered to $15 from $17 at Barclays 01/12/23 Morgan Stanley American Eagle assumed with an Underweight at Morgan Stanley AEO American Eagle $13.11 / +0.125 (+0.96%) 03/01/23 American Eagle sees FY23 revenue flat to up low-single digits, consensus $4.96B 03/01/23 American Eagle sees Q1 revenue flat to up low-single digits, consensus $1.07B 03/01/23 American Eagle reports Q4 adjusted EPS 37c, consensus 30c 03/01/23 Notable companies reporting after market close AEO American Eagle $13.11 / +0.125 (+0.96%) 03/06/23 Fly Insider: Domino's Pizza, American Eagle among week's notable insider trades 03/02/23 Fly Intel: Pre-market Movers 03/01/23 Fly Intel: After-Hours Movers 02/15/23 What You Missed On Wall Street On Wednesday AEO American Eagle $13.11 / +0.125 (+0.96%) 01/31/23 Unusually active option classes on open January 31st 01/05/23 American Eagle put volume heavy and directionally bearish 12/27/22 American Eagle put volume heavy and directionally bearish 12/13/22 American Eagle put volume heavy and directionally bearish
Downgrade	Urban Outfitters downgraded to Sell at UBS on softlines bearishness » 08:41 03/29/23 03/29 08:41 03/29/23 08:41 URBN Urban Outfitters $26.78 / +0.42 (+1.59%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options URBN Urban Outfitters $26.78 / +0.42 (+1.59%) 03/06/23 Urban Outfitters COO Conforti sells 42,000 common shares 02/28/23 Urban Outfitters says Q1 revenue growth could be 'similar to Q4' 02/28/23 Urban Outfitters reports comparable retail segment sales up 3% 01/09/23 Urban Outfitters reports holiday sales increased 2.3% URBN Urban Outfitters $26.78 / +0.42 (+1.59%) 06:17 Today UBS Urban Outfitters downgraded to Sell from Neutral at UBS 03/02/23 Barclays Urban Outfitters price target raised to $29 from $27 at Barclays 03/01/23 Deutsche Bank Deutsche Bank keeps Hold rating on Urban Outfitters, raises price target to $27 01/13/23 Barclays Urban Outfitters price target raised to $27 from $26 at Barclays URBN Urban Outfitters $26.78 / +0.42 (+1.59%) 02/28/23 Urban Outfitters reports Q4 EPS 34c, consensus 38c 11/21/22 Urban Outfitters reports Q3 EPS 40c, consensus 42c 11/21/22 Notable companies reporting after market close URBN Urban Outfitters $26.78 / +0.42 (+1.59%) 11/22/22 What You Missed On Wall Street On Tuesday 11/22/22 What You Missed On Wall Street This Morning URBN Urban Outfitters $26.78 / +0.42 (+1.59%) 02/01/23 Urban Outfitters put volume heavy and directionally bearish 01/05/23 Urban Outfitters put volume heavy and directionally bearish 11/21/22 Urban Outfitters options imply 7.9% move in share price post-earnings
Initiation	DexCom initiated with a Buy at UBS » 08:41 03/29/23 03/29 08:41 03/29/23 08:41 DXCM DexCom $113.75 / -2.17 (-1.87%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DXCM DexCom $113.75 / -2.17 (-1.87%) 03/21/23 DexCom announces expanded coverage for G6 CGM System in Manitoba 03/13/23 DexCom has no material exposure to developments at Silicon Valley Bank 03/06/23 DexCom down more than 7% after FDA gives nod to Abbott CGM sensors 03/02/23 DexCom CEO sells $4.23M in common stock DXCM DexCom $113.75 / -2.17 (-1.87%) 03/28/23 UBS DexCom initiated with a Buy at UBS 03/27/23 Jefferies DexCom Q1 report can be a catalyst for shares, says Jefferies 03/08/23 Jefferies DexCom pullback on Abbott news a buying opportunity, says Jefferies 03/07/23 BofA BofA says buy DexCom on weakness after Abbott's Libre gets pump integration DXCM DexCom $113.75 / -2.17 (-1.87%) 02/09/23 DexCom sees FY23 revenue of $3.35B-$3.49B, consensus $3.47B 02/09/23 DexCom reports Q4 EPS 22c, consensus 27c 02/09/23 Notable companies reporting after market close 01/09/23 DexCom sees Q revenue $2.91B, consensus $2.9B DXCM DexCom $113.75 / -2.17 (-1.87%) 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports DXCM DexCom $113.75 / -2.17 (-1.87%) 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 02/10/23 What You Missed On Wall Street On Friday 02/10/23 What You Missed On Wall Street This Morning 02/09/23 Fly Intel: After-Hours Movers DXCM DexCom $113.75 / -2.17 (-1.87%) 03/06/23 DexCom put volume heavy and directionally bearish 03/02/23 Early notable gainers among liquid option names on March 2nd 02/10/23 Early notable gainers among liquid option names on February 10th 02/09/23 DexCom options imply 6.0% move in share price post-earnings
Earnings	Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80 » 08:41 03/29/23 03/29 08:41 03/29/23 08:41 CTAS Cintas $443.89 / +3.48 (+0.79%) Consensus $12.73. Raises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CTAS Cintas $443.89 / +3.48 (+0.79%) 12/16/22 Cintas launches electric vehicle pilot program 11/15/22 Cintas expands cleanroom footprint with new facility in New York CTAS Cintas $443.89 / +3.48 (+0.79%) 12/22/22 Wells Fargo Cintas price target raised to $450 from $393 at Wells Fargo 12/22/22 Deutsche Bank Cintas price target raised to $507 from $490 at Deutsche Bank 12/22/22 Baird Cintas price target raised to $500 from $475 at Baird 12/22/22 Morgan Stanley Cintas price target raised to $401 from $373 at Morgan Stanley CTAS Cintas $443.89 / +3.48 (+0.79%) 08:37 Today Cintas reports Q4 EPS $3.14, consensus $3.04 12/21/22 Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65 12/21/22 Cintas reports Q2 EPS $3.12, consensus $3.03 CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 What You Missed On Wall Street On Wednesday 12/21/22 What You Missed On Wall Street This Morning 10:00 Today Cintas - CTAS
Downgrade	Foot Locker downgraded to Sell at UBS on softlines bearishness » 08:40 03/29/23 03/29 08:40 03/29/23 08:40 FL Foot Locker $40.04 / +1.11 (+2.85%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FL Foot Locker $40.04 / +1.11 (+2.85%) 03/20/23 Foot Locker focusing on banners, geographies that will drive growth, says CEO 03/20/23 Foot Locker to close stores, ecommerce in Hong Kong, Macau 11/29/22 Foot Locker announces leadership team appointments 11/18/22 Foot Locker rises 14.7% FL Foot Locker $40.04 / +1.11 (+2.85%) 06:17 Today UBS Foot Locker downgraded to Sell from Neutral at UBS 03/21/23 Deutsche Bank Foot Locker price target raised to $42 from $36 at Deutsche Bank 03/21/23 Morgan Stanley Morgan Stanley 'skeptical' of 'show-me' story Foot Locker's long-term targets 03/21/23 Evercore ISI Foot Locker upgraded to Outperform from In Line at Evercore ISI FL Foot Locker $40.04 / +1.11 (+2.85%) 03/20/23 Foot Locker targeting adjusted EPS growth in low to mid 20% range for FY24-FY26 03/20/23 Foot Locker sees FY23 adjusted EPS $3.35-$3.65, consensus $4.48 03/20/23 Foot Locker reports Q4 adjusted EPS 97c, consensus 51c 11/18/22 Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45 FL Foot Locker $40.04 / +1.11 (+2.85%) 10/26/22 Foot Locker to remove Yeezy products from stores, CNBC reports FL Foot Locker $40.04 / +1.11 (+2.85%) 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/20/23 What You Missed On Wall Street On Monday FL Foot Locker $40.04 / +1.11 (+2.85%) 03/13/23 Foot Locker put volume heavy and directionally bearish 03/13/23 Unusually active option classes on open March 13th 01/23/23 Foot Locker call volume above normal and directionally bullish 12/21/22 Unusually active option classes on open December 21st
Downgrade	Burlington Stores downgraded to Sell at UBS on softlines bearishness » 08:40 03/29/23 03/29 08:40 03/29/23 08:40 BURL Burlington Stores $201.18 / +1.7 (+0.85%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BURL Burlington Stores $201.18 / +1.7 (+0.85%) 11/22/22 Burlington Stores rises 14.5% 11/22/22 Burlington Stores rises 16.8% 11/22/22 Burlington Stores rises 17.0% 11/22/22 Burlington Stores CEO: 'We think the outlook for 2023 is very positive' BURL Burlington Stores $201.18 / +1.7 (+0.85%) 06:18 Today UBS Burlington Stores downgraded to Sell from Neutral at UBS 03/03/23 Deutsche Bank Burlington Stores price target raised to $235 from $214 at Deutsche Bank 03/03/23 Morgan Stanley Burlington Stores price target raised to $233 from $219 at Morgan Stanley 03/03/23 Baird Burlington Stores price target raised to $270 from $240 at Baird BURL Burlington Stores $201.18 / +1.7 (+0.85%) 03/02/23 Burlington Stores sees Q1 adjusted EPS 85c-95c, consensus 82c 03/02/23 Burlington Stores sees FY23 adjusted EPS $5.50-$6.00, consensus $6.65 03/02/23 Burlington Stores reports Q4 adjusted EPS $2.96, consensus $2.73 03/01/23 Notable companies reporting before tomorrow's open BURL Burlington Stores $201.18 / +1.7 (+0.85%) 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says BURL Burlington Stores $201.18 / +1.7 (+0.85%) 03/02/23 Fly Intel: Pre-market Movers 01/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/22/22 What You Missed On Wall Street On Tuesday BURL Burlington Stores $201.18 / +1.7 (+0.85%) 11/22/22 Unusually active option classes on open November 22nd 11/17/22 Burlington Stores call volume above normal and directionally bullish
Initiation	Zimmer Biomet initiated with a Sell at UBS » 08:39 03/29/23 03/29 08:39 03/29/23 08:39 ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) 01/05/23 Zimmer Biomet to acquire Embody for $155M at closing 11/30/22 NeuroOne Medical ships initial Zimmer Biomet order for Evo sEEG system 11/21/22 Zimmer Biomet announces FDA 510(k) clearance of Persona OsseoTi Keel Tibia 11/05/22 Zimmer Biomet announces one-year data from mymobility clinical study ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) 03/28/23 UBS Zimmer Biomet initiated with a Sell at UBS 03/10/23 Piper Sandler Zimmer upgraded to Overweight on 'conservative' outlook at Piper Sandler 03/09/23 Piper Sandler Zimmer Biomet upgraded to Overweight from Neutral at Piper Sandler 02/06/23 Loop Capital Zimmer Biomet price target raised to $140 from $125 at Loop Capital ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) 02/03/23 Zimmer Biomet sees FY23 adjusted EPS $6.95-$7.15, consensus $6.98 02/03/23 Zimmer Biomet reports Q4 EPS $1.88, consensus $1.83 02/02/23 Notable companies reporting before tomorrow's open 02/02/23 Notable companies reporting before tomorrow's open ZBH Zimmer Biomet $126.15 / +0.49 (+0.39%) 03/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/03/23 What You Missed On Wall Street This Morning 01/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Downgrade	Ross Stores downgraded to Sell at UBS on softlines bearishness » 08:39 03/29/23 03/29 08:39 03/29/23 08:39 ROST Ross Stores $103.12 / +2.51 (+2.49%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ROST Ross Stores $103.12 / +2.51 (+2.49%) 11/17/22 Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised 11/14/22 Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3 10/16/22 Fly Intel: Top five weekend stock stories ROST Ross Stores $103.12 / +2.51 (+2.49%) 06:18 Today UBS Ross Stores downgraded to Sell from Neutral at UBS 03/22/23 Loop Capital Loop upgrades Ross Stores to Buy on steady spending, conservative outlook 03/22/23 Loop Capital Ross Stores upgraded to Buy from Hold at Loop Capital 03/01/23 Deutsche Bank Ross Stores price target lowered to $120 from $121 at Deutsche Bank ROST Ross Stores $103.12 / +2.51 (+2.49%) 02/28/23 Ross Stores sees FY23 EPS $4.65-$4.95, consensus $5.09 02/28/23 Ross Stores sees Q1 EPS 99c-$1.05, consensus $1.18 02/28/23 Ross Stores reports Q4 EPS $1.31, consensus $1.24 02/28/23 Notable companies reporting after market close ROST Ross Stores $103.12 / +2.51 (+2.49%) 10/15/22 Shortages have turned to gluts, off-price retailers could benefit, Barron's says ROST Ross Stores $103.12 / +2.51 (+2.49%) 03/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/28/23 Fly Intel: After-Hours Movers 11/18/22 What You Missed On Wall Street On Friday 11/18/22 What You Missed On Wall Street This Morning ROST Ross Stores $103.12 / +2.51 (+2.49%) 03/22/23 Early notable gainers among liquid option names on March 22nd 11/28/22 Ross Stores put volume heavy and directionally bearish 11/18/22 Early notable gainers among liquid option names on November 18th 11/17/22 Ross Stores options imply 4.9% move in share price post-earnings
Earnings	Paychex sees FY23 EPS growth of of 13%-14%, consensu $4.24 » 08:39 03/29/23 03/29 08:39 03/29/23 08:39 PAYX Paychex $108.88 / -0.1 (-0.09%) The company's … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PAYX Paychex $108.88 / -0.1 (-0.09%) 01/24/23 Paychex appoints Theresa Payton to Board of Directors 12/28/22 Paychex VP Gioja sells $1.6M in company shares 12/11/22 Fly Intel: Top five weekend stock stories 10/14/22 Paychex names President and CEO John Gibson, Jr. to board PAYX Paychex $108.88 / -0.1 (-0.09%) 03/13/23 Barclays Paychex price target lowered to $105 from $110 at Barclays 01/17/23 Barclays Paychex downgraded to Underweight from Equal Weight at Barclays 01/03/23 Deutsche Bank Paychex price target lowered to $116 from $123 at Deutsche Bank 12/27/22 Evercore ISI Paychex price target lowered to $114 from $117 at Evercore ISI PAYX Paychex $108.88 / -0.1 (-0.09%) 08:36 Today Paychex reports Q3 EPS $1.29, consensus $1.24 03/28/23 Notable companies reporting before tomorrow's open 03/28/23 Notable companies reporting before tomorrow's open 12/22/22 Paychex raises FY23 adjusted EPS view to up 12%-14% from up 11%-12% PAYX Paychex $108.88 / -0.1 (-0.09%) 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says PAYX Paychex $108.88 / -0.1 (-0.09%) 12/23/22 What You Missed On Wall Street On Friday 12/23/22 What You Missed On Wall Street This Morning 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 09:30 Today Paychex - PAYX
Downgrade	Bath & Body Works downgraded to Neutral at UBS on softlines bearishness » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/06/23 Bath & Body Works announces appointment of Kuhn to board of directors 02/27/23 Bath & Body Works calls Third Point's potential proxy contest 'misguided' 02/23/23 Bath & Body Works taking enterprise-wide effort to reduce expenses 02/23/23 Bath & Body Works responds to Third Point intent to nominate board candidates BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 06:19 Today UBS Bath & Body Works downgraded to Neutral from Buy at UBS 03/23/23 Piper Sandler Bath & Body Works price target lowered to $48 from $52 at Piper Sandler 03/17/23 Argus Bath & Body Works cut to Hold at Argus on online competition, slowing sales 03/17/23 Argus Bath & Body Works downgraded to Hold from Buy at Argus BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 02/23/23 Bath & Body Works sees FY23 cont ops EPS $2.50-$3.00, consensus $3.16 02/23/23 Bath & Body Works sees Q1 cont ops EPS 17c-27c, consensus 44c 02/23/23 Bath & Body Works reports Q4 cont ops EPS $1.86, consensus $1.62 02/22/23 Notable companies reporting before tomorrow's open BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 02/22/23 Third Point plans proxy fight at Bath & Body Works, WSJ reports 02/22/23 Third Point plans proxy fight at Bath & Body Works, WSJ reports BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 Fly Intel: Pre-market Movers 02/22/23 What You Missed On Wall Street On Wednesday 02/15/23 What You Missed On Wall Street On Wednesday BBWI Bath & Body Works $38.05 / +1.375 (+3.75%) 03/28/23 Early notable gainers among liquid option names on March 28th 03/22/23 Early notable gainers among liquid option names on March 22nd 02/16/23 Bath & Body Works call volume above normal and directionally bullish 02/01/23 Bath & Body Works call volume above normal and directionally bullish
Initiation	Inspire Medical initiated with a Buy at UBS » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 INSP Inspire Medical $238.42 / -9.82 (-3.96%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSP Inspire Medical $238.42 / -9.82 (-3.96%) 03/21/23 Inspire Medical announces FDA approval for pediatric patients with Down Syndrome 03/09/23 Inspire Medical receives countrywide reimbursement approval in Belgium 12/20/22 Inspire Medical publishes inaugural ESG summary report INSP Inspire Medical $238.42 / -9.82 (-3.96%) 03/28/23 UBS Inspire Medical initiated with a Buy at UBS 02/08/23 Lake Street Inspire Medical price target raised to $305 from $250 at Lake Street 02/08/23 Truist Inspire Medical price target raised to $330 from $310 at Truist 02/08/23 Piper Sandler Inspire Medical price target raised to $305 from $300 at Piper Sandler INSP Inspire Medical $238.42 / -9.82 (-3.96%) 02/07/23 Inspire Medical reports Q4 EPS 10c, consensus (57c) 01/09/23 Inspire Medical sees FY22 revenue $407.5M-$407.9M, consensus $387.61M 01/09/23 Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M 11/01/22 Inspire Medical raises FY22 revenue view to $384M-$388M from $354M-$362M 12 Aug INSP Inspire Medical $238.42 / -9.82 (-3.96%) 01/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/27/23 Inspire Medical Systems, Inc.
Recommendations	Biomea Fusion price target raised to $47 from $25 at Oppenheimer » 08:38 03/29/23 03/29 08:38 03/29/23 08:38 BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) Oppenheimer raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion trading resumes 03/28/23 Biomea Fusion trading halted, volatility trading pause 03/28/23 Biomea Fusion announces data from ongoing Phase II study of BMF-219 01/17/23 Biomea Fusion doses first patient in COVALENT-102 trial of BMF-219 BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 06:06 Today Citi Biomea Fusion price target raised to $60 from $20 at Citi 03/28/23 H.C. Wainwright Biomea Fusion price target raised to $44 from $37 at H.C. Wainwright 03/28/23 Piper Sandler Biomea Fusion price target raised to $40 from $16 at Piper Sandler 02/24/23 Citi Biomea Fusion initiated with a Buy at Citi BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion reports Q4 EPS (21c), consensus (81c) 11/07/22 Biomea Fusion reports Q3 EPS (78c), consensus (65c) 30 Mar BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning BMEA Biomea Fusion $30.74 / +15.27 (+98.71%) 03/28/23 Biomea Fusion options imply 11.3% move in share price post-earnings
Earnings	Cintas reports Q4 EPS $3.14, consensus $3.04 » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 CTAS Cintas $443.89 / +3.48 (+0.79%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CTAS Cintas $443.89 / +3.48 (+0.79%) 12/16/22 Cintas launches electric vehicle pilot program 11/15/22 Cintas expands cleanroom footprint with new facility in New York CTAS Cintas $443.89 / +3.48 (+0.79%) 12/22/22 Wells Fargo Cintas price target raised to $450 from $393 at Wells Fargo 12/22/22 Deutsche Bank Cintas price target raised to $507 from $490 at Deutsche Bank 12/22/22 Baird Cintas price target raised to $500 from $475 at Baird 12/22/22 Morgan Stanley Cintas price target raised to $401 from $373 at Morgan Stanley CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65 12/21/22 Cintas reports Q2 EPS $3.12, consensus $3.03 CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 What You Missed On Wall Street On Wednesday 12/21/22 What You Missed On Wall Street This Morning 10:00 Today Cintas - CTAS
Hot Stocks	Taoping enters long-term strategic cooperation agreement with Zhaoyuan City » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 TAOP Taoping / + Taoping has entered into… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News TAOP Taoping / + 03/17/23 Taoping receives Nasdaq minimum bid price requirement extension 11/17/22 Taoping signs three-year strategic cooperation agreement with ZhongShengShi Co. 11/09/22 Taoping signs three-year cooperation agreement with DoWatch Technology 10/18/22 Taoping enters into strategic cooperation with Jiangsu SuLiXin
Hot Stocks	BK Technologies receives $781K order for KNG Series mobile radios » 08:37 03/29/23 03/29 08:37 03/29/23 08:37 BKTI BK Technologies $2.98 / -0.15 (-4.79%) BK Technologies received… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BKTI BK Technologies $2.98 / -0.15 (-4.79%) 03/16/23 BK Technologies board decides to suspend quarterly cash dividend 03/09/23 BK Technologies receives purchase order for InteropONE PTToC service 03/08/23 WidePoint signs reseller agreement with BK Technologies 03/08/23 BK Technologies signs reseller agreement with WidePoint BKTI BK Technologies $2.98 / -0.15 (-4.79%) 09/19/22 ThinkEquity BK Technologies initiated with a Buy at ThinkEquity BKTI BK Technologies $2.98 / -0.15 (-4.79%) 03/16/23 BK Technologies reports Q4 EPS (6c) vs. (2c) last year 11/03/22 BK Technologies reports Q3 EPS (14c) vs. (15c) last year
Initiation	Boston Scientific initiated with a Buy at UBS » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 BSX Boston Scientific $48.60 / +0.265 (+0.55%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BSX Boston Scientific $48.60 / +0.265 (+0.55%) 01/11/23 Boston Scientific targeting 'double digit' EPS growth in 2023, consensus $1.93 12/11/22 Fly Intel: Top five weekend stock stories 12/11/22 Boston Scientific to acquire majority stake of Acotec Scientific 11/29/22 Apollo Endosurgery to be acquired by Boston Scientific for $10.00 per share BSX Boston Scientific $48.60 / +0.265 (+0.55%) 03/28/23 UBS Boston Scientific initiated with a Buy at UBS 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 02/17/23 Argus Boston Scientific price target raised to $55 from $50 at Argus 02/02/23 Needham Boston Scientific price target raised to $53 from $48 at Needham BSX Boston Scientific $48.60 / +0.265 (+0.55%) 02/01/23 Boston Scientific sees FY23 adjusted EPS $1.86-$1.93, consensus $1.93 02/01/23 Boston Scientific sees Q1 adjusted EPS 42c-44c, consensus 44c 02/01/23 Boston Scientific reports Q4 adjusted EPS 45c, consensus 47c 01/31/23 Notable companies reporting before tomorrow's open BSX Boston Scientific $48.60 / +0.265 (+0.55%) 12/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/29/22 What You Missed On Wall Street On Tuesday 11/29/22 What You Missed On Wall Street This Morning 10/26/22 What You Missed On Wall Street This Morning 05/04/23 Boston Scientific Corporation BSX Boston Scientific $48.60 / +0.265 (+0.55%) 01/11/23 Boston Scientific put volume heavy and directionally bearish
Hot Stocks	CytoSorbents announces study on CytoSorb hemoperfusion » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 CTSO CytoSorbents $3.39 / +0.055 (+1.65%) CytoSorbents highlights… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 03/22/23 CytoSorbents highlights new data to prevent endothelial damage to blood vessels 03/14/23 CytoSorbents reports no direct exposure to SVB, Signature Bank 03/07/23 CytoSorbents announces new European guidelines that consider hemoadsorption 01/23/23 CytoSorbents' STAR-T trial receives Health Canada regulatory approval CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 05/04/22 B. Riley CytoSorbents price target lowered to $6 from $7 at B. Riley CTSO CytoSorbents $3.39 / +0.055 (+1.65%) 03/09/23 CytoSorbents reports Q4 revenue $9.4M, consensus $8.72M 01/31/23 CytoSorbents sees Q4 revenue $9.4M, consensus $8.9M 11/03/22 CytoSorbents reports Q3 EPS (28c), consensus (16c)

Hot Stocks	Foretell Reality partners with UMD Robert H. Smith School of Business » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 VRAR Glimpse Group $3.64 / -0.04 (-1.09%) The Glimpse Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 03/22/23 QReal enters contractto develop AR experience for Denny's 02/27/23 Brightline Interactive signs CRADA with U.S. NSWCDD 02/21/23 PulpoAR announces Fingernail Segmentation, Skin Diagnostics integration 02/09/23 Glimpse Israel selected by Israeli Ministry of Education as key partner VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 12/19/22 EF Hutton Glimpse Group assumed with a Buy at EF Hutton VRAR Glimpse Group $3.64 / -0.04 (-1.09%) 02/14/23 Glimpse Group options imply 13.9% move in share price post-earnings
Earnings	Paychex reports Q3 EPS $1.29, consensus $1.24 » 08:36 03/29/23 03/29 08:36 03/29/23 08:36 PAYX Paychex $108.88 / -0.1 (-0.09%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PAYX Paychex $108.88 / -0.1 (-0.09%) 01/24/23 Paychex appoints Theresa Payton to Board of Directors 12/28/22 Paychex VP Gioja sells $1.6M in company shares 12/11/22 Fly Intel: Top five weekend stock stories 10/14/22 Paychex names President and CEO John Gibson, Jr. to board PAYX Paychex $108.88 / -0.1 (-0.09%) 03/13/23 Barclays Paychex price target lowered to $105 from $110 at Barclays 01/17/23 Barclays Paychex downgraded to Underweight from Equal Weight at Barclays 01/03/23 Deutsche Bank Paychex price target lowered to $116 from $123 at Deutsche Bank 12/27/22 Evercore ISI Paychex price target lowered to $114 from $117 at Evercore ISI PAYX Paychex $108.88 / -0.1 (-0.09%) 03/28/23 Notable companies reporting before tomorrow's open 03/28/23 Notable companies reporting before tomorrow's open 12/22/22 Paychex raises FY23 adjusted EPS view to up 12%-14% from up 11%-12% 12/22/22 Paychex reports Q2 adjusted EPS 99c, consensus 95c PAYX Paychex $108.88 / -0.1 (-0.09%) 12/10/22 Microsoft, Arista among stocks that can survive a triple whammy, Barron's says PAYX Paychex $108.88 / -0.1 (-0.09%) 12/23/22 What You Missed On Wall Street On Friday 12/23/22 What You Missed On Wall Street This Morning 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning 09:30 Today Paychex - PAYX
Initiation	Craig-Hallum bullish on Gambling.com, initiates with a Buy » 08:35 03/29/23 03/29 08:35 03/29/23 08:35 GAMB Gambling.com $9.51 / -0.22 (-2.26%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/08/23 Gambling.com ready to launch online sports betting in MA with BetMassachusetts 02/08/23 Gannett sees strategic partnership with Gambling.com as immediately accretive GAMB Gambling.com $9.51 / -0.22 (-2.26%) 07:20 Today Craig-Hallum Gambling.com initiated with a Buy at Craig-Hallum 11/18/22 Stifel Gambling.com price target raised to $12 at Stifel after 'solid' Q3 10/25/22 Truist Gambling.com price target raised to $12 from $10.50 at Truist 08/30/22 Truist Gambling.com price target lowered to $10.50 from $12 at Truist GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/23/23 Gambling.com reports Q4 adjusted EPS 2c, consensus 2c 11/17/22 Gambling.com backs FY22 revenue $71M-$76M, consensus $71M 11/17/22 Gambling.com reports Q3 adjusted EPS 16c, two estimates 5c GAMB Gambling.com $9.51 / -0.22 (-2.26%) 03/24/23 Bet On It: New York weekly wagering numbers see March Madness bump 11/17/22 Fly Intel: After-Hours Movers GAMB Gambling.com $9.51 / -0.22 (-2.26%) 10/19/22 Twelve new option listings and two option delistings on October 19th
Initiation	Insulet initiated with a Neutral at UBS » 08:35 03/29/23 03/29 08:35 03/29/23 08:35 PODD Insulet $311.43 / -3.26 (-1.04%) In a sector note on U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly PODD Insulet $311.43 / -3.26 (-1.04%) 03/15/23 Insulet to replace SVB Financial in S&P 500 at open on 3/15 03/10/23 Insulet to replace SVB Financial in S&P 500 at open on 3/15 03/10/23 Insulet to replace SVB Financial in S&P 500 02/14/23 Insulet acquires assets of Automated Glucose Control for $25M PODD Insulet $311.43 / -3.26 (-1.04%) 03/28/23 UBS Insulet initiated with a Neutral at UBS 02/24/23 Raymond James Insulet price target raised to $334 from $320 at Raymond James 02/24/23 Baird Insulet price target raised to $350 from $340 at Baird 02/24/23 Barclays Insulet price target raised to $292 from $245 at Barclays PODD Insulet $311.43 / -3.26 (-1.04%) 02/23/23 Insulet sees FY23 revenue growth 14%-19%, consensus $1.47B 02/23/23 Insulet sees Q1 revenue growth 11%-14%, consensus $333.86M 02/23/23 Insulet reports Q4 adjusted EPS 55c, consensus 21c 11/03/22 Insulet raises FY22 revenue growth view to 18%-19% from 14%-17% PODD Insulet $311.43 / -3.26 (-1.04%) 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports PODD Insulet $311.43 / -3.26 (-1.04%) 02/23/23 Fly Intel: After-Hours Movers 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 10/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Earnings	IM Cannabis reports Q4 EPS ($1.28) vs. (19c) last year » 08:34 03/29/23 03/29 08:34 03/29/23 08:34 IMCC IM Cannabis / + Reports Q4 continuing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research IMCC IM Cannabis / + 10/12/22 Avant Brands, IM Cannabis launch BLKMKT in Israel 10/12/22 Avant Brands, IM Cannabis announce the launch of BLK MKT in Israel IMCC IM Cannabis / + 08/16/22 Alliance Global Partners IM Cannabis price target lowered to $1.50 from $6 at Alliance Global Partners

Events

Earnings calls, analyst events, roadshows and more

RDW
Today at 09:00

Redwire - RDW Conference Calls
BOSC
Today at 09:00

BOS Better Online Solutions - BOSC Conference Calls
IBEX
Today at 09:00

Ibex - IBEX Conference Calls
UNF
Today at 09:00

UniFirst - UNF Conference Calls
CLH
Today at 09:00

Clean Harbors Firm Sponsored Meetings

Virtual Meeting
PAYX
Today at 09:30

Paychex - PAYX Conference Calls
RMR
Today at 09:30

The RMR Group Inc. Firm Sponsored Meetings
Today at 10:00

Joint Committee Meeting Government Event

Teleconference
Today at 10:00

Pending Home Sales Index M/M: February 2023 Government Event
Today at 10:00

Pending Home Sales Index: February 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	BMEA X BMEA Biomea Fusion Secondary Managers: JPMorgan & Citi, Oppenheimer, Barclays $30.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

Housing stocks are down, but there are signs of rebound, Barron's says

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access